Biological Sample Collection Kits Global Market Report 2024

The biological sample collection kits market size has grown rapidly in recent years. It will grow from $9.09 billion in 2023 to $10.2 billion in 2024 at a compound annual growth rate (CAGR) of 12.2%. The growth observed during the historic period can be attributed to several factors, including increased awareness of disease screening, a rise in home healthcare services, the growing geriatric population, heightened focus on preventive medicine, and the expansion of infectious disease testing initiatives.

The biological sample collection kits market size is expected to see rapid growth in the next few years. It will grow to $16.23 billion in 2028 at a compound annual growth rate (CAGR) of 12.3%. The anticipated growth in the forecast period can be attributed to several factors, including the increasing preference for point-of-care testing, a rising incidence of chronic diseases, growing demand for remote patient monitoring, heightened emphasis on preventive healthcare, and increasing awareness about infectious diseases. Major trends expected in the forecast period include the adoption of point-of-care testing, technological advancements in the field, the utilization of microfluidics technology, the advancement of personalized medicine approaches, and the expansion of remote patient monitoring capabilities.

The upward trend in infectious diseases is anticipated to drive the expansion of the market for biological sample collection kits in the future. Infectious diseases stem from pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, which can spread from person to person. Factors contributing to the rise in infectious diseases include increased global travel, urbanization, antimicrobial resistance, environmental shifts, and insufficient healthcare infrastructure. Biological sample collection kits play a vital role in managing infectious diseases by facilitating the safe and efficient collection of specimens for diagnosis, monitoring, and research purposes. For example, according to the Centers for Disease Control and Prevention, the United States recorded 8,331 tuberculosis (TB) cases in 2022, representing a 5.9% increase from 2021. The incidence rate was 2.5 cases per 100,000 people, reflecting a 5.5% rise compared to the previous year. Hence, the surge in infectious diseases is fostering the growth of the biological sample collection kits market.

Key players in the biological sample collection kits market are focusing on the development of innovative products, such as personalized diagnostic test kits, to cater to customers' evolving needs with advanced functionalities. Personalized diagnostic test kits are designed to detect specific biomarkers or genetic information tailored to an individual's unique health profile, enabling customized medical diagnoses. For instance, Cue Health, a US-based diagnostic test service provider, introduced at-home diagnostic test kits in March 2023. These kits contain all necessary supplies for safe, easy, and private sample collection. After the sample is processed by an independent, CLIA-certified laboratory, the customer receives clear and understandable results securely through the Cue Health App, along with relevant information about their condition or concern.

In May 2022, Babson Diagnostics Inc., a US-based healthcare company, expanded its strategic partnership with Becton, Dickinson, and Company to improve diagnostic blood collection in novel care settings. This expanded collaboration builds upon their previous efforts to develop a capillary blood collection and testing system tailored for retail environments, ensuring laboratory-quality results with small-volume capillary blood samples. Becton Dickinson and Company, a US-based medical technology company, manufactures various medical devices, including biological sample collection kits.

Major companies operating in the biological sample collection kits market are Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, 3M Company, Danaher Corporation, Medline Industries Inc., Siemens Healthineers, Becton, Dickinson and Company, Quest Diagnostics, Avantor Inc., Hologic Inc., Formlabs Inc., Hardy Diagnostics Co, Puritan Medical Products Inc., Copan Diagnostics Inc., HiMedia Laboratories Pvt. Ltd., Omega Laboratories Ltd, VIRCELL S.L., Titan Biotech Ltd., BTNX Inc., Mantacc, FL Medical S.R.L.

North America was the largest region in the biological sample collection kits market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological sample collection kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biological sample collection kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Biological sample collection kits are essential tools crafted for the safe and efficient gathering, preservation, and transportation of biological specimens such as blood, saliva, urine, or tissue. These kits typically comprise sterile containers, swabs, and preservatives, ensuring the samples' integrity for diagnostic or research purposes.

The primary types of biological sample collection kits include swabs, viral transport media, blood collection kits, and others. Swabs serve as instruments for gathering samples from different body sites for medical testing, commonly featuring a soft tip affixed to a stick. These kits find applications in diagnostics and research and are utilized by various end users such as hospitals, clinics, home testing facilities, diagnostics centers, and more.

The biological sample collection kits research report is one of a series of new reports that provides biological sample collection kits market statistics, including the biological sample collection kits industry's global market size, regional shares, competitors with a biological sample collection kits market share, detailed biological sample collection kits market segments, market trends and opportunities, and any further data you may need to thrive in the biological sample collection kits industry. This biological sample collection kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biological sample collection kits market consists of sales of blood collection tubes, saliva collection devices, urine collection containers, swabs for microbial sampling, and tissue biopsy kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.